Use of single nucleotide polymorphism microarrays to distinguish between balanced and normal chromosomes in embryos from a translocation carrier
|
|
- Ferdinand Doyle
- 5 years ago
- Views:
Transcription
1 CASE REPORT Use of single nucleotide polymorphism microarrays to distinguish between balanced and normal chromosomes in embryos from a translocation carrier Nathan R. Treff, Ph.D., a,b Xin Tao, M.S., a Wendy J. Schillings, M.D., c Paul A. Bergh, M.D., a,b Richard T. Scott Jr., M.D., a,b and Brynn Levy, Ph.D. a,d a Reproductive Medicine Associates of New Jersey, Morristown, New Jersey; b Division of Reproductive Endocrinology and Infertility, Department of Obstetrics Gynecology and Reproductive Science, University of Medicine and Dentistry of New Jersey (UMDNJ) Robert Wood Johnson Medical School, New Brunswick, New Jersey; c Reproductive Medicine Associates of Pennsylvania, Allentown, Pennsylvania; and d Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York Objective: To prove the ability to distinguish between balanced and normal chromosomes in embryos from a translocation carrier. Design: Case report. Setting: Academic center for reproductive medicine. Patient(s): Woman with a balanced translocation causing Alagille syndrome seeking preimplantation genetic diagnosis (PGD). Intervention(s): Blastocyst biopsy for PGD. Main Outcome Measure(s): Consistency of 3 methods of embryo genetic analysis (real-time polymerase chain reaction, single nucleotide polymorphism [SNP] microarray, and fluorescence in situ hybridization [FISH]) and normalcy in the newborn derived from PGD. Result(s): PGD was applied to 48 embryos. Real-time polymerase chain reaction, SNP microarray, and FISH demonstrated 100% consistency, although FISH failed to detect aneuploidies observed by comprehensive SNP microarray-based analyses. Two blastocysts were identified to be normal for all 3 factors using SNP microarray technology alone. The 2 normal embryos were transferred back to the patient, resulting in the delivery of a healthy boy with a normal karyotype. Conclusion(s): This is the first report of validation and successful clinical application of microarray-based PGD to distinguish between balanced and normal chromosomes in embryos from a translocation carrier. (Fertil Steril Ò 2011;96:e Ó2011 by American Society for Reproductive Medicine.) Key Words: Aneuploidy, preimplantation embryo, Alagille syndrome, translocation, microdeletion Received February 23, 2011; revised April 12, 2011; accepted April 13, 2011; published online May 14, N.R.T. has received research grants from EMD Serono, Ferring, Schering Plough, and Barr Pharmaceuticals. X.T. has nothing to disclose. W.J.S. has nothing to disclose. P.A.B. has nothing to disclose. R.T.S. has received research grants from EMD Serono, Ferring, Schering Plough, and Barr Pharmaceuticals. B.L. is a member of the advisory board for Affymetrix. Reprint requests: Nathan R. Treff, Ph.D., Reproductive Medicine Associates of New Jersey Research, 111 Madison Avenue, Suite 100, Morristown, NJ ( ntreff@rmanj.com). It is estimated that 1 in 625 individuals carries a balanced translocation (1). In most cases, carriers are phenotypically normal, but they are at increased risk for clinical pregnancy loss and offspring with congenital abnormalities and/or mental retardation as a result of unbalanced segregation during gametogenesis. A clinical phenotype may also result if there is disruption of critical gene(s) at the breakpoint regions. Studies using newer molecular cytogenetic techniques have now demonstrated that microdeletions are responsible for a proportion of cases in which an apparently balanced translocation is associated with phenotypic abnormality (2 4). In fact, small genomic imbalances such as microdeletions, as well as duplications or inversions, occur at or near the chromosomal breakpoint in 10% to 60% of cases (4 12). A good example is Alagille syndrome (ALGS), which is caused by mutations in the Jagged1 gene (13, 14). There are now a few reports of patients with ALGS with apparently balanced translocations, all of which share a common breakpoint on chromosome 20 at p12.2 (13 15). A microdeletion encompassing the Jagged1 gene has been demonstrated in some of these cases (13, 14) and presumed in the others. Individuals carrying this type of genetic abnormality who are interested in producing healthy offspring through preimplantation genetic diagnosis (PGD) would require more careful screening than is currently available. The primary aim of PGD would be to distinguish between embryos carrying the balanced translocation (and accompanying microdeletion) and those with truly normal chromosomes. A previously developed single nucleotide polymorphism (SNP) microarray based method of aneuploidy screening (16) e58 Fertility and Sterility â Vol. 96, No. 1, July /$36.00 Copyright ª2011 American Society for Reproductive Medicine, Published by Elsevier Inc. doi: /j.fertnstert
2 FIGURE 1 Workup results of a patient with ALGS. (A) Conventional karyotype analysis confirmed an apparently balanced translocation, 46,XX,t(2;20)(q21;p12.2). (B) SNP oligonucleotide microarray analysis copy number (CN) analysis of chromosome 20 revealed a microdeletion (including the Jagged1 locus) that causes ALGS. The expanded view of cytoband 20p12.2 indicates the dbsnp rs identifiers for each of the 6 SNPs identified as informative and used in the subsequent triple-factor PGD of embryos derived from the patient during 2 IVF cycles. (C) Real-time polymerase chain reaction results for lymphocyte samples from the patient, partner, or mixture of the 2 illustrating the expected genotypes of homozygous opposite for each intended parent and heterozygous for the mixtures. Genomic DNA of each sample served as a control for the expected genotypes of the 5-cell samples. (D) Confirmation of the 2.36-Mb deletion using fluorescence in situ hybridization (FISH) with probe RPC I10 (Jagged1 locus). Only 1 copy of the Jagged1 locus, on the normal chromosome 20, is present. Fertility and Sterility â e59
3 TABLE 1 Preclinical ALGS real-time PCR assay validation. Sample type Analysis Informative SNPs rs rs rs rs rs rs Maternal gdna Microarray result C T G T A A gdna TaqMan result C T G T A A 5-cell C T G T A A 5-cell C T G T A A 5-cell C T G T A A 5-cell C T G T A A Paternal gdna Microarray result TT CC AA CC GG GG gdna TaqMan result TT CC AA CC GG GG 5-cell TT CC AA CC GG GG 5-cell TT CC AA CC GG GG 5-cell TT CC AA CC GG GG 5-cell TT CC AA CC GG GG Mixed parental 4 maternal:2 paternal cells TaqMan result CT TC GA TC AG AG 4 maternal:2 paternal cells CT TC GA TC AG AG 4 maternal:2 paternal gdna CT TC GA TC AG AG 4 maternal:2 paternal gdna CT TC GA TC AG AG Note: PCR ¼ polymerase chain reaction. offers an opportunity do so. This method was recently used to simultaneously detect unbalanced chromosome derivatives and aneuploidy of all 24 chromosomes in embryos from patients carrying balanced translocations (17). Therefore, the ability of SNP microarrays to detect an inherited microdeletion associated with an apparently balanced translocation was investigated in the present study. This proof-of-principle study also represents the first clinical application of simultaneous detection of a single gene disorder, unbalanced chromosome derivatives, and aneuploidy of all 24 chromosomes from the same embryo biopsy. MATERIALS AND METHODS Patient and Case Workup A 28-year-old patient with ALGS with an apparently balanced translocation 46,XX,t(2;20)(q21;p12.2) (Fig. 1A) presented for PGD. The presence of a putative microdeletion was investigated by analysis of DNA isolated from peripheral blood of the patient and her partner. Chromosome copy number was evaluated by SNP microarray analysis as previously described (16). Informative SNPs were identified based on the criteria that the patient and partner were homozygous for 2 different (opposite) alleles within the putative microdeletion. SNP microarray data described in this study were deposited in the Gene Expression Omnibus of the National Center for Biotechnology Information and are accessible through GEO series accession number GSE21732 ( geo). Assays TaqMan SNP genotyping based predesigned allelic discrimination assays (Applied Biosystems Inc., Foster City, CA) were selected from the informative SNPs on the Affymetrix Nsp I SNP microarray (Affymetrix, Santa Clara, CA) that defined the boundaries of the microdeletion in the patient (Table 1). Each assay was evaluated on lymphocyte samples derived from the patient and her partner either separately (5 cells) or in a 2:1 mixture (patient cell:partner cell ratio; 6 cells) to mimic heterozygosity. Cells were prepared by alkaline lysis as previously described (16). Preamplification of the SNP assay target DNA was conducted on each sample using TaqMan PreAmp Master Mix as recommended by the supplier (Applied Biosystems Inc.) and before conventional allelic discrimination based analysis. Embryos found suitable for cryopreservation in the first of 2 IVF treatment cycles were biopsied for trophectoderm tissue at the blastocyst stage as previously described (18). Half of each trophectoderm biopsy was preincubated in a hypotonic solution and fixed using 3:1 methanol:acetic acid solution. Three rounds of fluorescence in situ hybridization (FISH) were performed using probes for the unbalanced translocation derivatives, the microdeletion, and aneuploidy of chromosomes 18, X, and Y. Further details are available upon request. The second half of each trophectoderm biopsy (unused by FISH) from the first of 2 IVF cycles, as well as the arrested embryos from both cycles, and the entire trophectoderm biopsy of embryos from the second cycle were placed into polymerase chain reaction (PCR) tubes for cell lysis as previously described (16). Each lysate was split into 2 PCR tubes. One tube was processed by microarray analysis of [1] aneuploidy of all 24 chromosomes as previously described (16), [2] unbalanced derivative chromosomes as previously described (17), and [3] the microdeletion as described in Patient and Case Workup. The second PCR tube containing a split aliquot from the embryo lysates was processed by real-time PCR to determine the presence or absence of the microdeletion. Each SNP was genotyped as described in Patient and Case Workup. Newborn DNA DNA was isolated from a newborn buccal swab using the QIAamp DNeasy Tissue kit as recommended for cell cultures (QIAgen e60 Treff et al. Array-based balanced translocation test Vol. 96, No. 1, July 2011
4 Fertility and Sterility â e61 TABLE 2 Results of PGD for all embryos and tests used. Sample EM no. Microarray result FISH result TaqMan result rs rs rs rs rs rs Cycle 1 TE 1 45,XX, 13 Normal female CT TC GA TC AG AG TE 2 46,XY,t(2;20)(q21;p12.2) Male with ALGS T C A C G G TE 3 47,XX,þder(2)t(2;20)(q21;p12.2),þ17, 20 Unbalanced female T C A C G G TE 4 46,XX, 2,þder(20)t(2;20)(q21;p12.2) Indeterminate female CT TC GA TC AG AG TE 5 46,XX,t(2;20)(q21;p12.2) ALGS ND C A C G G TE 6 45,XX, 2 Unbalanced CT TC GA TC GA GA Arrested EM 7 46,XX,þ2, 20 T C A C G G Arrested EM 8 46,XX,der(20)t(2;20)(q21;p12.2) T C A C G G Arrested EM 9 46,XX,der(2)t(2;20)(q21;p12.2) CT CT AG CT AG AG Arrested EM 10 46,XY,der(20)t(2;20)(q21;p12.2) T ND A C G G Arrested EM 11 45,XY, 20 ND ND ND ND ND ND Arrested EM 12 46,XY,þder(2)t(2;20)(q21;p12.2), 20 T C A C G G Arrested EM 13 46,XY,þder(20)t(2;20)(q21;p12.2), 2 CT CT AG CT AG AG Arrested EM 14 45,XY,der(2)t(2;20)(q21;p12.2), 20 T C A C G G Arrested EM 15 46,XX,der(2)t(2;20)(q21;p12.2), 20 T C A C G G Arrested EM 16 47,XX,þ2,þ19, 20 T C A C G G Arrested EM 17 42,XY, 1, 5, 6,der(2)t(2;20)(q21;p12.2), T ND A ND G G þder(2)t(2;20)(q21;p12.2), 17, 20 Arrested EM 18 47,XY, 2,der(20)t(2;20)(q21;p12.2), CT CT AG CT AG AG þder(20)t(2;20)(q21;p12.2),þ20 Arrested EM 19 46,XY,der(2)t(2;20)(q21;p12.2), T C A C G G þder(2)t(2;20)(q21;p12.2), 12,þ16, 20 Cycle 2 TE 20 a 46,XY CT TC GA TC AG AG TE 21 46,XY (indeterminate q6) CT TC GA TC AG AG TE 22 45,XX,der(2)t(2;20)(q21;p12.2), 14 CT TC GA TC AG AG TE 23 46,XX, 2,þder(20)t(2;20)(q21;p12.2) CT TC GA TC AG AG TE 24 47,XY,þ15,der(20)t(2;20)(q21;p12.2) T C A C G G TE 25 45,XX,der(20)t(2;20)(q21;p12.2), 22 T C A C G G TE 26 46,XY,der(20)t(2;20)(q21;p12.2) T C A C G G TE 27 a 46,XY CT TC GA TC AG AG TE 28 46,XY, 2,der(20)t(2;20)(q21;p12.2), T C A C G G þder(20)t(2;20)(q21;p12.2) TE 29 45,XY, 20 T C A C G G TE 30 47,XY,der(20)t(2;20)(q21;p12.2),þ10 ND C A ND G G Arrested EM 31 47,XY, 2,þ16,þder(20)t(2;20)(q21;p12.2) CT TC GA TC AG AG Arrested EM 32 46,XY, 2,þder(20)t(2;20)(q21;p12.2) CT TC GA TC AG AG Arrested EM 33 45,XY, 6,der(20)t(2;20)(q21;p12.2) T C A C G G Arrested EM 34 46,XX,der(2)t(2;20)(q21;p12.2) CT TC GA TC AG AG Arrested EM 35 46XX,þder(2)t(2;20)(q21;12.2), 20 T C A C G G Arrested EM 36 47,XY,þ2,der(20)t(2;20)(q21;p12.2) ND CC AA CC GG GG Arrested EM 37 46,XX CT ND GA ND ND GG
5 TABLE 2 Continued. TaqMan result rs rs rs rs rs rs Sample EM no. Microarray result FISH result Arrested EM 38 46,XX, 1, 2,þ6,þder(20)t(2;20)(q21;p12.2) CT TC GA TC AG AG Arrested EM 39 46,XY,der(2)t(2;20)(q21;p12.2),þ20, 22 CT TC GA TC AG AG Arrested EM 40 46,XX,der(2)t(2;20)(q21;p12.2) CT TC GA TC AG AG Arrested EM 41 46,XX CT TC GA TC AG AG Arrested EM 42 No result CT ND GA CC ND GG Arrested EM 43 46,XY CT TC GA TC AG AG Arrested EM 44 45,XY,þder(2)t(2;20)(q21;p12.2), 16, 20 TT CC AA CC GG GG Arrested EM 45 46,XY, 1,þ10, 16,der(20)t(2;20)(q21;p12.2) TT CC AA CC GG GG Arrested EM 46 46,XY,der(20)t(2;20)(q21;p12.2) TT CC AA CC GG GG CT TC GA TC AG AG Arrested EM 47 47,XX, 2,der(20)t(2;20)(q21;p12.2), þder(20)t(2;20)(q21;p12.2),þ20 Arrested EM 48 46,XX, 4,þ8,t(2;20)(q21;p12.2) TT CC AA CC GG GG Note: EM ¼ embryo; TE ¼ trophectoderm. a Selected for transfer. Inc., Valencia, CA). Microarray detection of whole chromosome aneuploidy and microdeletions was conducted as described in Assays. ALGS real-time PCR was also performed as described in Assays. A conventional karyotype of the newborn was prepared by a cytogenetic reference laboratory. Ethics All materials were collected under institutional review board approval, and analysis was conducted with patient consent. RESULTS Microarray analysis revealed a 2.36-Mb microdeletion on the short arm of chromosome 20 in the patient with ALGS (Fig. 1B). Six real-time PCR based genotyping assays across the microdeletion were selected for further validation and were consistent with the original SNP microarray based genotyping (Table 1). Real-time PCR of preamplified DNA from maternal, paternal, and mixed maternal and paternal lymphocytes were also reliably and accurately genotyped (Table 1, Fig. 1C). In addition to the real-time PCR based detection of the microdeletion, a FISH probe for the Jagged1 locus was also validated by analysis of cells from the patient (Fig. 1D). The first treatment cycle resulted in the development of 19 embryos, of which 6 developed into morphologically normal cryopreservable blastocysts (Table 2). FISH analysis alone would have identified a single embryo as eligible for embryo transfer (Table 3). However, the embryo that was identified as eligible for transfer by FISH (embryo 1) displayed a monosomy of chromosome 13 by microarray (Fig. 2). With the criteria previously defined and validated for whole-chromosome aneuploidy (16), 2 embryos (embryo 2 and embryo 5) were diagnosed as either balanced or normal (Fig. 2). However, further analysis with the microdeletion settings (1-Mb smoothing) within the 20p12.2 segment resulted in these 2 embryos being diagnosed as abnormal (Fig. 2). Therefore, microarray analysis indicated that none of the embryos from the first treatment cycle were genetically normal. Although FISH was not as comprehensive as microarray, the 2 techniques were 100% consistent for the common regions that they assessed (Table 3). ALGS real-time PCR genotypes were consistent with expectations from microarray copy number assignments in all cases (Fig. 2). Overall, the ALGS real-time PCR based microdeletion predictions were 100% consistent with the SNP microarray and FISH-based microdeletion analyses (Table 3). Because FISH-based analysis was proven to be redundant in the presence of microarray- and real-time PCR based analyses (Table 3), embryos from the second treatment cycle were not screened by FISH. The second cycle led to the development of 29 embryos, of which 11 blastocysts were biopsied and cryopreserved (Table 2). Two of the 11 cryopreservable blastocysts were found to be euploid for all 24 chromosomes and negative for the presence of the microdeletion by both real-time PCR and microarray (Fig. 3A). Both embryos were thawed and transferred, resulting in the implantation and delivery of a genetically normal boy as confirmed by microarray (Fig. 3A), real-time PCR (Fig. 3B), and conventional karyotyping (Fig. 3C) of the newborn. DISCUSSION This is the first clinical case of microarray-based PGD being used to distinguish between balanced and normal chromosomes in embryos from a translocation carrier. Initial experience with SNP e62 Treff et al. Array-based balanced translocation test Vol. 96, No. 1, July 2011
6 TABLE 3 PGD results from cycle 1. Sample EM no. Microarray result FISH result TaqMan result rs rs rs rs rs rs TE 1 45,XX, 13 Normal female CT TC GA TC AG AG TE 2 46,XY,t(2;20)(q21;p12.2) Male with ALGS T C A C G G TE 3 47,XX,þder(2)t(2;20)(q21;p12.2), Unbalanced T C A C G G þ17, 20 female TE 4 46,XX, 2, Indeterminate CT TC GA TC AG AG þder(20)t(2;20)(q21;p12.2) female TE 5 46,XX,t(2;20)(q21;p12.2) ALGS ND C A C G G TE 6 45,XX, 2 Unbalanced CT TC GA TC GA GA Note: TE ¼ trophectoderm. microarray based aneuploidy and translocation screening indicated that 32% of developmentally competent blastocysts were balancednormal and euploid (17). Interestingly, analysis of DNA from the 17 patients who were translocation carriers did not reveal microdeletions near the breakpoints of either of the 2 chromosomes involved in the translocation. This was not unexpected given the lack of a clinical phenotype in those patients. The methodology described here may be more applicable to cases in which an apparently balanced FIGURE 2 (A) Microarray analysis of embryos derived from the first IVF cycle of the patient with a balanced translocation, 46,XX,t(2;20)(q21;p12.2), and ALGS caused by a microdeletion of 20p12.2. The 2 embryos (embryo 2 and embryo 5) diagnosed as either balanced or normal using the predefined chromosome aneuploidy analysis settings were subsequently identified as balanced ALGS carriers after the microdeletion analysis settings were used within 20p12. (B) Real-time PCR based analysis of the microdeletion was consistent with SNP microarray results. Fertility and Sterility â e63
7 FIGURE 3 SNP microarray and real-time PCR based analysis result (rs ) of (A) 2 embryos selected for transfer and (B) the resulting newborn. Both embryos and the resulting newborn were euploid and negative for the microdeletion. The newborn was found to be unaffected by ALGS and karyotypically normal by conventional G-banding analysis (C) and represents the first successful outcome following PGD to distinguish balanced from normal chromosomes in embryos from a translocation carrier. translocation has resulted in manifestation of a clinical disorder (i.e., ALGS). However, recently described methods of SNP microarray based haplotyping (19) might be used to distinguish between normal and balanced chromosomes in embryos from phenotypically normal translocation carriers. The data set described here represents an important and unique resource to validate such methodologies because it is the only SNP microarray data from embryos with known normal or balanced karyotypes. Therefore, the present study may represent an important step toward more generalized application of PGD to distinguish between balanced and normal chromosomes in embryos from translocation carriers. Although this advance may not be critical to the immediate goal of producing a healthy child for most translocation carriers, it may represent an important option for these patients to prevent their children from facing the same difficulties with reproduction in the future. Acknowledgment: The authors thank Lesley Northrop, Ph.D., for help with depositing the microarray data and preparation of the figures and tables. e64 Treff et al. Array-based balanced translocation test Vol. 96, No. 1, July 2011
8 REFERENCES 1. Van Dyke D, Weiss L, Roberson J, Babu V. The frequency and mutation rate of balanced autosomal rearrangements in man estimated from prenatal genetic studies for advanced maternal age. Am J Hum Genet 1983;35: Simovich MJ, Yatsenko SA, Kang SHL, Cheung SW, Dudek ME, Pursley A, et al. Prenatal diagnosis of a 9q34.3 microdeletion by array-cgh in a fetus with an apparently balanced translocation. Prenat Diagn 2007;27: Shanske AL, Edelmann L, Kardon NB, Gosset P, Levy B. Detection of an interstitial deletion of 2q21 22 by high resolution comparative genomic hybridization in a child with multiple congenital anomalies and an apparent balanced translocation. Am J Med Genet 2004;131A: Astbury C, Christ LA, Aughton DJ, Cassidy SB, Kumar A, Eichler EE, et al. Detection of deletions in de novo balance chromosome rearrangements: further evidence for their role in phenotypic abnormalities. Gene Med 2004;6: Kirchhoff M, Rose H, Lundsteen C. High resolution comparative genomic hybridization in clinical cytogenetics. J Med Genet 2001;38: Borg I, Squire M, Menzel C, Stout K, Morgan D, Willatt L, et al. A cryptic deletion of 2q35 including part of the PAX3 gene detected by breakpoint mapping in a child with autism and a de novo 2;8 translocation. J Med Genet 2002;39: Borg K, Stankiewicz P, Bocian E, Kruczek A, Obersztyn E, Lupski J, et al. Molecular analysis of a constitutional complex genome rearrangement with 11 breakpoints involving chromosomes 3, 11, 12, and 21 and a 0.5-Mb submicroscopic deletion in a patient with mild mental retardation. Hum Genet 2005;118: Vissers L, de Vries B, Osoegawa K, Janssen I, Feuth T, Choy C, et al. Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 2003;73: Tyson C, McGillivray B, Chijiwa C, Rajcan- Separovic E. Elucidation of a cryptic interstitial 7q31.3 detection in a patient with a language disorder and mild mental retardation by array-cgh. Am J Hum Genet Part A 2004;129A: Shaw-Smith C, Redon R, Rickman L, Rio M, Willatt L, Fiegler H, et al. Microarray based comparative genomic hybridisation (array-cgh) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet 2004;41: Gribble S, Prigmore E, Burford D, Porter K, Bee Ling N, Douglas E, et al. The complex nature of constitutional de novo apparently balanced translocations in patients presenting with abnormal phenotypes. J Med Genet 2005;42: Cheung S, Shaw C, Yu W, Li J, Ou Z, Patel A, et al. Development and validation of a CGH microarray for clinical cytogenetic diagnosis. Genet Med 2005;7: Krantz ID, Rand EB, Genin A, Hunt P, Jones M, Louis AA, et al. Deletions of 20p12 in Alagille syndrome: frequency and molecular characterization. Am J Med Genet 1997;70: Oda T, Elkahloun AG, Meltzer PS, Okajima K, Sugiyama K, Wada Y, et al. Identification of a larger than 3 Mb deletion including JAG1 in an Alagille syndrome patient with a translocation t(3;20)(q13.3;p12.2). Hum Mutat 2000; 16: Hattori M, Miyake Y, Oda T, Okajima K, Mizuno K, Sugiyama K, et al. Alagille syndrome with t(3;20)(q13.3;p12.2). Nippon Shonika Gakkai Zasshi 1995;99: Treff NR, Su J, Tao X, Levy B, Scott RT Jr. Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays. Fertil Steril 2010;94: Treff NR, Northrop LE, Kasabwala K, Su J, Levy B, Scott RT Jr. Single nucleotide polymorphism microarray-based concurrent screening of 24 chromosome aneuploidy and unbalanced translocations in preimplantation human embryos. Fertil Steril 2011;95: e Treff NR, Su J, Kasabwala N, Miller KA, Levy B, Scott RT. Robust embryo identification using first polar body single nucleotide polymorphism (SNP) microarray-based DNA fingerprinting. Fertil Steril 2010;93: Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara NA, Shaw MA, et al. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet 2010;47: Fertility and Sterility â e65
SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation carrier and normal blastocysts
J Assist Reprod Genet (2016) 33:1115 1119 DOI 10.1007/s10815-016-0734-0 TECHNOLOGICAL INNOVATIONS SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation
More informationDevelopment of new comprehensive
Development and validation of an accurate quantitative real-time polymerase chain reaction based assay for human blastocyst comprehensive chromosomal aneuploidy screening Nathan R. Treff, Ph.D., a,b Xin
More informationComprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study
ORIGINAL ARTICLES: ASSISTED REPRODUCTION Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study Richard T. Scott
More informationAccurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays
Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays Nathan R. Treff, Ph.D., a,b Jing Su, M.Sc., a Xin Tao, M.Sc., a Brynn
More informationChallenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014
Challenges of CGH array testing in children with developmental delay Dr Sally Davies 17 th September 2014 CGH array What is CGH array? Understanding the test Benefits Results to expect Consent issues Ethical
More informationCHROMOSOMAL MICROARRAY (CGH+SNP)
Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due
More informationDiagnosis of parental balanced reciprocal translocations by trophectoderm biopsy and comprehensive chromosomal screening
Diagnosis of parental balanced reciprocal translocations by trophectoderm biopsy and comprehensive chromosomal screening Lian Liu, MD Co-Authors: L. W. Sundheimer1, L. Liu2, R. P. Buyalos1,3, G. Hubert1,3,
More informationTargeted qpcr. Debate on PGS Technology: Targeted vs. Whole genome approach. Discolsure Stake shareholder of GENETYX S.R.L
Antonio Capalbo, PhD Laboratory Director GENETYX, reproductive genetics laboratory, Italy PGT responsible GENERA centers for reproductive medicine, Italy Debate on PGS Technology: Targeted vs. Whole genome
More informationBlastocyst preimplantation genetic diagnosis (PGD) of a mitochondrial DNA disorder
ORIGINAL ARTICLES: GENETICS Blastocyst preimplantation genetic diagnosis (PGD) of a mitochondrial DNA disorder Nathan R. Treff, Ph.D., a,b,c Jessyca Campos, M.S., a,b Xin Tao, M.S., a Brynn Levy, Ph.D.,
More informationApplications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns
Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns جواد کریمزاد حق PhD of Medical Genetics آزمايشگاه پاتوبيولوژي و ژنتيك پارسه
More informationBlastocentesis: innovation in embryo biopsy
Blastocentesis: innovation in embryo biopsy L. Gianaroli, MC Magli, A. Pomante, AP Ferraretti S.I.S.Me.R. Reproductive Medicine Unit, Bologna, Italy Bologna, 8-11 May 2016 www.iiarg.com www.sismer.it 2013
More informationSNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.
SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: LOSS,
More informationSNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.
SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: GAIN,
More informationCYTOGENETICS Dr. Mary Ann Perle
CYTOGENETICS Dr. Mary Ann Perle I) Mitosis and metaphase chromosomes A) Chromosomes are most fully condensed and clearly distinguishable during mitosis. B) Mitosis (M phase) takes 1 to 2 hrs and is divided
More informationA novel single-cell DNA fingerprinting method successfully distinguishes sibling human embryos
A novel single-cell DNA fingerprinting method successfully distinguishes sibling human embryos Nathan R. Treff, Ph.D., a,b Jing Su, M.Sc., a Xin Tao, M.Sc., a Kathleen A. Miller, B.Sc., a Brynn Levy, M.Sc.(Med).,
More informationPreimplantation Genetic Testing
Protocol Preimplantation Genetic Testing (40205) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization No Review Dates: 09/11, 09/12, 09/13 The following Protocol contains medical
More informationPGS & PGD. Preimplantation Genetic Screening Preimplantation Genetic Diagnosis
1 PGS & PGD Preimplantation Genetic Screening Preimplantation Genetic Diagnosis OUR MISSION OUR MISSION CooperGenomics unites pioneering leaders in reproductive genetics, Reprogenetics, Recombine, and
More informationChromosomal Aneuploidy
The Many Advantages of Trophectoderm Biopsy Compared to Day 3 Biopsy for Pre- Implantation Genetic Screening (PGS) Mandy Katz-Jaffe, PhD Chromosomal Aneuploidy Trisomy 21 Fetus Aneuploidy is the most common
More informationComprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks?
Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks? Embryo 1 Embryo 2 combine samples for a single sequencing chip Barcode 1 CTAAGGTAAC
More informationCURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
More informationApproach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD
Approach to Mental Retardation and Developmental Delay SR Ghaffari MSc MD PhD Introduction Objectives Definition of MR and DD Classification Epidemiology (prevalence, recurrence risk, ) Etiology Importance
More informationPrenatal Diagnosis: Are There Microarrays in Your Future?
Financial Disclosure UCSF Antepartum Intrapartum Management Course June 8 I have no financial relationship with any aspect of private industry Prenatal Diagnosis: Are There Microarrays in Your Future?
More informationCanadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010
Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination May 4, 2010 Examination Length = 3 hours Total Marks = 100 (7 questions) Total Pages = 8 (including cover sheet and 2 pages of prints)
More informationEmbryoCellect TM. Pre-implantation Genetic Screening Kit TECHNICAL INFORMATION
EmbryoCellect TM Pre-implantation Genetic Screening Kit TECHNICAL INFORMATION Aneuploidy Whole chromosome aneuploidy has been shown to affect all chromosomes in IVF embryos. Aneuploidy is a significant
More information24-Feb-15. Learning objectives. Family genetics: The future??? The traditional genetics. Genetics and reproduction in early 2015.
Learning objectives Family genetics: The future??? Peter Illingworth Medical Director IVFAustralia Understand how genetic problems may affect successful conception Consider the possible conditions and
More informationADVANCED PGT SERVICES
Genomic Prediction ADVANCED PGT SERVICES with PGT-A using SEQ is a cost-effective, rigorously validated, unambiguous, and streamlined test for aneuploidy in blastocyst biopsies, and uses state of the art
More informationAn Update on PGD: Where we are today
An Update on PGD: Where we are today Joyce Harper UCL Centre for PG&D and CRGH Institute for Womens Health University College London Overview What is PGD/PGS How we do it Disadvantages and advantages Future
More informationPregnancy outcomes following 24-chromosome preimplantation genetic diagnosis in couples with balanced reciprocal or Robertsonian translocations
Pregnancy outcomes following 24-chromosome preimplantation genetic diagnosis in couples with balanced reciprocal or Robertsonian translocations Dennis Idowu, M.D., a Katrina Merrion, M.S., b Nina Wemmer,
More informationDetection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit
APPLICATION NOTE Ion PGM System Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit Key findings The Ion PGM System, in concert with the Ion ReproSeq PGS View Kit and Ion Reporter
More informationA Stepwise Approach to Embryo Selection and Implantation Success
Precise Genetic Carrier Screening An Overview A Stepwise Approach to Embryo Selection and Implantation Success Put today s most advanced genetic screening technology to work for you and your family s future.
More informationMultiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016
Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Marwan Tayeh, PhD, FACMG Director, MMGL Molecular Genetics Assistant Professor of Pediatrics Department of Pediatrics
More informationChromosome pathology
Chromosome pathology S. Dahoun Department of Gynecology and Obstetrics, University Hospital of Geneva Cytogenetics is the study of chromosomes and the related disease states caused by abnormal chromosome
More informationNEXCCS. Your guide to aneuploidy screening
NEXCCS Your guide to aneuploidy screening GROWING FAMILIES What is comprehensive chromosome screening? Comprehensive chromosome screening (CCS), also known as preimplantation genetic screening (PGS) or
More informationUnderstanding the Human Karyotype Colleen Jackson Cook, Ph.D.
Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. SUPPLEMENTAL READING Nussbaum, RL, McInnes, RR, and Willard HF (2007) Thompson and Thompson Genetics in Medicine, 7th edition. Saunders: Philadelphia.
More informationSharan Goobie, MD, MSc, FRCPC
Sharan Goobie, MD, MSc, FRCPC Chromosome testing in 2014 Presenter Disclosure: Sharan Goobie has no potential for conflict of interest with this presentation Objectives Review of standard genetic investigations
More informationTechnical Update: Preimplantation Genetic Diagnosis and Screening
No. 323, May 2015 (Replaces No. 232, August 2009) Technical Update: Preimplantation Genetic Diagnosis and Screening This technical update has been prepared by the Genetics Committee and approved by the
More informationCase 1B. 46,XY,-14,+t(14;21)
Case 1B 46,XY,-14,+t(14;21) G-banded Chromosome telomere centromere G-dark bands AT-rich few genes G-pale bands GC-rich many genes telomere ideograms ideograms Conventional (light microscopy) p = short
More informationNew and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads
New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads Susan Gross, MD Division of Reproductive Genetics Professor
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationCHROMOSOME MICROARRAY TESTING (NON-ONCOLOGY CONDITIONS)
CHROMOSOME MICROARRAY TESTING (NON-ONCOLOGY CONDITIONS) UnitedHealthcare Oxford Clinical Policy Policy Number: LABORATORY 016.12 T2 Effective Date: June 1, 2018 Table of Contents Page INSTRUCTIONS FOR
More informationIncrease your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)
Increase your chance of IVF Success PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0) What is PGT-A? PGT-A, or Preimplantation Genetic Testing for Aneuploidy (PGS 2.0), is a type of genomic
More informationAbstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online; on web 10 December 2003
RBMOnline - Vol 8. No 2. 224-228 Reproductive BioMedicine Online; www.rbmonline.com/article/1133 on web 10 December 2003 Article Preimplantation genetic diagnosis for early-onset torsion dystonia Dr Svetlana
More informationStructural Variation and Medical Genomics
Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,
More informationDetermination of Genomic Imbalances by Genome-wide Screening Approaches
Overview Determination of Genomic Imbalances by Genome-wide Screening Approaches Károly Szuhai Introduction/Methodologies Applications/Results Conclusion Approaches Introduction/Methodologies Chromosome
More informationChromosome Abnormalities
Chromosome Abnormalities Chromosomal abnormalities vs. molecular mutations Simply a matter of size Chromosomal abnormalities are big errors Two types of abnormalities 1. Constitutional problem present
More informationCorporate Medical Policy
Corporate Medical Policy Invasive Prenatal (Fetal) Diagnostic Testing File Name: Origination: Last CAP Review: Next CAP Review: Last Review: invasive_prenatal_(fetal)_diagnostic_testing 12/2014 3/2018
More informationCIC Edizioni Internazionali. Preimplantation genetic screening: definition, role in IVF, evolution and future perspectives. Summary.
Mini-review Preimplantation genetic screening: definition, role in IVF, evolution and future perspectives Antonio Capalbo 1 Cristina Poggiana 2 Cristina Patassini 2 Anna Checchele 2 Emiliano Scepi 2 Danilo
More informationProblem Challenge Need. Solution Innovation Invention
Problem Challenge Need Solution Innovation Invention Tubal Infertility In-vitro Fertilisation Steptoe and Edwards Birth after the reimplantation of a human embryo. Lancet 1978 Louise Brown, 25. Juli 1978
More informationSNP microarray-based 24 chromosome aneuploidy screening is significantly more consistent than FISH
Molecular Human Reproduction, Vol.16, No.8 pp. 583 589, 2010 Advanced Access publication on May 19, 2010 doi:10.1093/molehr/gaq039 NEW RESEARCH HORIZON Review SNP microarray-based 24 chromosome aneuploidy
More informationA Retrospective Study of Balanced Chromosomal Translocations in a Turkish Population
Kamla-Raj 2012 Int J Hum Genet, 12(4): 319-323 (2012) A Retrospective Study of Balanced Chromosomal Translocations in a Turkish Population N. Karakus 1, N. Kara 1, S. Tural 1, I. Kocak 2 and M. Elbistan
More informationArticle Pre-embryonic diagnosis for Sandhoff disease
RBMOnline - Vol 12. No 3. 2006 328-333 Reproductive BioMedicine Online; www.rbmonline.com/article/2100 on web 9 January 2006 Article Pre-embryonic diagnosis for Sandhoff disease Dr Anver Kuliev received
More informationAssociation for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology
Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology 9650 Rockville Pike, Bethesda, Maryland 20814 Tel: 301-634-7939 Fax: 301-634-7990 Email:
More informationIVF Michigan, Rochester Hills, Michigan, and Reproductive Genetics Institute, Chicago, Illinois
FERTILITY AND STERILITY VOL. 80, NO. 4, OCTOBER 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. CASE REPORTS Preimplantation
More informationValidation of Next-Generation Sequencer for 24-Chromosome Aneuploidy Screening in Human Embryos
GENETIC TESTING AND MOLECULAR BIOMARKERS Volume 21, Number 11, 2017 ª Mary Ann Liebert, Inc. Pp. 1 7 DOI: 10.1089/gtmb.2017.0108 ORIGINAL ARTICLE Validation of Next-Generation Sequencer for 24-Chromosome
More information@ CIC Edizioni Internazionali. Origin and mechanisms of aneuploidies in preimplantation embryos
Review article Preimplantation genetic screening: definition, role in IVF, evolution and future perspectives Antonio Capalbo 1 Cristina Poggiana 1 Cristina Patassini 1 Anna Cecchele 1 Emiliano Scepi 1
More informationGenetic Testing 101: Interpreting the Chromosomes
Genetic Testing 101: Interpreting the Chromosomes Kristin Lindstrom, MD Division of Genetics and Metabolism Phoenix Children s Hospital AzAAP Pediatrics in the Red Rocks I have no disclosures for this
More information7.1 Molecular Characterization of Fragile X Syndrome
7 GENETIC DISORDERS Advances in knowledge of molecular genetics, cytogenetics and biochemical genetics have led to availability of diagnostic tests for various genetic disorders. The most important application
More informationPATIENT CONSENT FORM Preimplantation Genetic Screening (PGS) 24 Chromosome Aneuploidy and Translocation Screening with acgh
PREIMPLANTATION GENETIC SCREENING FOR ANEUPLOIDY SCREENING INTRODUCTION Preimplantation genetic screening (PGS) is used in conjunction with in-vitro fertilization (IVF) to screen embryos for numerical
More informationRapid genomic screening of embryos using nanopore sequencing
Rapid genomic screening of embryos using nanopore sequencing Daniel J Turner, PhD Senior Director of Applications Oxford Nanopore Technologies Forman EJ & Scott RT Jr Contemporary OB/GYN () 2014 Euploid
More informationShort Report. B Lakhal a, R Braham b, R Berguigua a, N Bouali a, M Zaouali c, M Chaieb b, RA Veitia d,e,f, A Saad a,g and H Elghezal a,g
Clin Genet 2010: 78: 181 185 Printed in Singapore. All rights reserved Short Report 2010 John Wiley & Sons A/S CLINICAL GENETICS doi: 10.1111/j.1399-0004.2009.01359.x Cytogenetic analyses of premature
More informationMULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.
Exam Chapter 15 Chromosomal Basis for Inheritance AP Biology Name MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question. 1) When Thomas Hunt Morgan crossed
More informationChromosome microarray analysis in routine prenatal diagnosis practice: a prospective study on 3000 consecutive clinical cases
Chromosome microarray analysis in routine prenatal diagnosis practice: a prospective study on 3000 consecutive clinical cases Fiorentino F, Napoletano S, Caiazzo F, Sessa M, Bono S, Spizzichino L, Gordon
More informationMedical Policy Preimplantation Genetic Testing
Medical Policy Preimplantation Genetic Testing Document Number: 004 Commercial* and Connector/ Qualified Health Plans Authorization required X No notification or authorization Not covered * Not all commercial
More informationArticle Preimplantation diagnosis and HLA typing for haemoglobin disorders
RBMOnline - Vol 11. No 3. 2005 362-370 Reproductive BioMedicine Online; www.rbmonline.com/article/1853 on web 20 July 2005 Article Preimplantation diagnosis and HLA typing for haemoglobin disorders Dr
More informationCommittee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler
Committee Paper Committee: Scientific and Clinical Advances Advisory Committee Meeting Date: 12 May 2009 Agenda Item: 4 Paper Number: SCAAC(05/09)01 Paper Title: ICSI guidance Author: Hannah Darby and
More informationScientific and Clinical Advances Advisory Committee Paper
Scientific and Clinical Advances Advisory Committee Paper Paper title Paper number SCAAC(06/15)07 Meeting date 10 June 2015 Agenda item 7 Author Information/decision Resource implications Implementation
More informationMALBAC Technology and Its Application in Non-invasive Chromosome Screening (NICS)
MALBAC Technology and Its Application in Non-invasive Chromosome Screening (NICS) The Power of One Adapted from Internet Single Cell Genomic Studies Ultra Low Sample Input Advances and applications of
More informationPreimplantation genetic diagnosis: polar body and embryo biopsy
Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director
More informationBIOLOGY - CLUTCH CH.15 - CHROMOSOMAL THEORY OF INHERITANCE
!! www.clutchprep.com Chromosomal theory of inheritance: chromosomes are the carriers of genetic material. Independent Assortment alleles for different characters sort independently of each other during
More informationSummary of 328 samples from 59 patients received for preimplantation genetic screening by array CGH: hints at early stage embryo development
Summary of 328 samples from 59 patients received for preimplantation genetic screening by array CGH: hints at early stage embryo development Teresa A. Smolarek, PhD Division of Human Genetics, Department
More informationLIST OF INVESTIGATIONS
Karyotyping: K001 K002 LIST OF INVESTIGATIONS SAMPLE CONTAINER TYPE cells For Karyotyping [Single] cells For Karyotyping [Couple] Vacutainer Vacutainer 7-8 7-8 K003 Fetal Blood Sample For Karyotyping Vacutainer
More informationTHE CHROMOSOMAL BASIS OF INHERITANCE CHAPTER 15
THE CHROMOSOMAL BASIS OF INHERITANCE CHAPTER 15 What you must know: Inheritance in sex-linked genes. Inheritance of linked genes and chromosomal mapping. How alteration of chromosome number or structurally
More informationMPS for translocations
MPS for translocations Filip Van Nieuwerburgh, Ph.D. Lab of Pharmaceutical Biotechnology NXTGNT massively parallel sequencing facility, Ghent University In collaboration with: Center for Medical Genetics,
More informationNational Medical Policy
National Medical Policy Subject: Policy Number: Single Nucleotide Polymorphism (SNP) Chromosomal Microarray Analysis for Prenatal Testing and Intellectual Disability, Developmental Delay, and Multiple
More informationGenome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro
Original Research Article American College of Medical Genetics and Genomics Open Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in
More informationPre-implantation genetic diagnosis and pre-implantation genetic screening: two years experience at a single center
Original Article Obstet Gynecol Sci 2018;61(1):95-101 https://doi.org/10.5468/ogs.2018.61.1.95 pissn 2287-8572 eissn 2287-8580 Pre-implantation genetic diagnosis and pre-implantation genetic screening:
More informationClinical Genomics. Ina E. Amarillo, PhD FACMGG
Clinical Genomics Ina E. Amarillo, PhD FACMGG Associate Medical Director, Cytogenetics Lab (CaTG), Lab and Genomic Medicine Assistant Professor, Pathology and Immunology Outline Clinical Genomics Testing
More informationApplication of Whole Genome Microarrays in Cancer: You should be doing this test!!
Application of Whole Genome Microarrays in Cancer: You should be doing this test!! Daynna Wolff, Ph.D. Director, Cytogenetics and Genomics Disclosures Clinical Laboratory Director and Employee, Medical
More informationApplication of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation
Pediatr Neonatol 2008;49(6):213 217 REVIEW ARTICLE Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation Jao-Shwann Liang 1,2 *, Keiko Shimojima
More informationClinical applications of preimplantation genetic testing
Clinical applications of preimplantation genetic testing Paul R Brezina, 1 2 William H Kutteh 1 2 1 Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Vanderbilt
More informationPractical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs
Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs Joris Vermeesch, Center for Human Genetics K.U.Leuven, Belgium ESHG June 11, 2010 When and
More informationGenetics and Reproductive Options for SMA Families Annual SMA Conference Dallas, Texas Friday, June 15, 2017
Genetics and Reproductive Options for SMA Families 2018 Annual SMA Conference Dallas, Texas Friday, June 15, 2017 Part 1: SMA and Genetics Louise R Simard, PhD Part 2: SMA Carrier Screening Melissa Gibbons,
More informationC H A P T E R Molecular Genetics Techniques for Preimplantation Genetic Diagnosis
Author, please provide citation of references 82, 83 in the text C H A P T E R Molecular Genetics 16 Techniques for Preimplantation Genetic Diagnosis Francesco Fiorentino, Gayle M Jones Introduction HISTORICAL
More informationThe Survey of Double Robertsonian Translocation 13q; 14q in the Pedigree of 44; XX Woman: A Case Report
Downloaded from ijmcmed.org at 13:18 +0430 on Sunday August 19th 2018 [ DOI: 10.22088/BUMS.6.4.243 ] IJMCM Autumn 2017, Vol 6, No 4 DOI: 10.22088/BUMS.6.4.243 Case report The Survey of Double Robertsonian
More informationLab Activity 36. Principles of Heredity. Portland Community College BI 233
Lab Activity 36 Principles of Heredity Portland Community College BI 233 Terminology of Chromosomes Homologous chromosomes: A pair, of which you get one from mom, and one from dad. Example: the pair of
More informationStatistical Analysis of Single Nucleotide Polymorphism Microarrays in Cancer Studies
Statistical Analysis of Single Nucleotide Polymorphism Microarrays in Cancer Studies Stanford Biostatistics Workshop Pierre Neuvial with Henrik Bengtsson and Terry Speed Department of Statistics, UC Berkeley
More informationFrom the earliest years of IVF, it
24-chromosome copy number analysis: a comparison of available technologies Alan H. Handyside, M.A., Ph.D. Bluegnome, Fulbourn, Cambridge; and Institute of Integrative and Comparative Biology, University
More informationPolar Body Approach to PGD. Anver KULIEV. Reproductive Genetics Institute
Polar Body Approach to PGD Anver KULIEV Reproductive Genetics Institute DISCLOSURE othing to disclose 14 History of Polar Body Approach 14 First proposed in World Health Organization s Document Perspectives
More informationPreimplantation Genetic Testing Where are we going? Genomics Clinical Medicine Symposium Sept 29,2012 Jason Flanagan, MS,CGC
Preimplantation Genetic Testing Where are we going? Genomics Clinical Medicine Symposium Sept 29,2012 Jason Flanagan, MS,CGC Overview Discuss what PGD and PGS are Pt examples What we have learned Where
More informationPaul R. Brezina, Raymond Anchan & William G. Kearns
Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences? Paul R. Brezina, Raymond Anchan & William G. Kearns Journal of Assisted Reproduction and Genetics
More informationGenomic structural variation
Genomic structural variation Mario Cáceres The new genomic variation DNA sequence differs across individuals much more than researchers had suspected through structural changes A huge amount of structural
More informationDiagnostic Techniques to Improve the Assessment of Human IVF Embryos: Genomics and Proteomics
Diagnostic Techniques to Improve the Assessment of Human IVF Embryos: Genomics and Proteomics Mandy G Katz-Jaffe Introduction A fundamental component of assisted reproductive technologies (ART) is the
More informationWhat s the Human Genome Project Got to Do with Developmental Disabilities?
What s the Human Genome Project Got to Do with Developmental Disabilities? Disclosures Neither speaker has anything to disclose. Phase Two: Interpretation Officially started in October 1990 Goals of the
More informationUCLA UCLA Previously Published Works
UCLA UCLA Previously Published Works Title Recent advances in preimplantation genetic diagnosis and screening. Permalink https://escholarship.org/uc/item/6gc712qc Journal Journal of assisted reproduction
More informationComprehensive chromosome screening and embryo biopsy: advantages and difficulties. Antonio Capalbo, PhD Italy
Comprehensive chromosome screening and embryo biopsy: advantages and difficulties Antonio Capalbo, PhD Italy Disclosure Antonio Capalbo, PhD GEERA, Reproductive medicine centers GEETYX, molecular genetics
More informationThe Chromosomal Basis of Inheritance
The Chromosomal Basis of Inheritance Factors and Genes Mendel s model of inheritance was based on the idea of factors that were independently assorted and segregated into gametes We now know that these
More informationGenetic Testing for Single-Gene and Multifactorial Conditions
Clinical Appropriateness Guidelines Genetic Testing for Single-Gene and Multifactorial Conditions EFFECTIVE DECEMBER 1, 2017 Appropriate.Safe.Affordable 2017 AIM Specialty Health 2069-1217 Table of Contents
More informationreview Genetics IN Medicine 13
January 2008 Vol. 10 No. 1 review Pre- and postnatal genetic testing by array-comparative genomic hybridization: genetic counseling perspectives Sandra Darilek, MS, Patricia Ward, MS, Amber Pursley, MS,
More informationChapter 15 Notes 15.1: Mendelian inheritance chromosome theory of inheritance wild type 15.2: Sex-linked genes
Chapter 15 Notes The Chromosomal Basis of Inheritance Mendel s hereditary factors were genes, though this wasn t known at the time Now we know that genes are located on The location of a particular gene
More informationCase Report Persistent Mosaicism for 12p Duplication/Triplication Chromosome Structural Abnormality in Peripheral Blood
Case Reports in Genetics Volume 2013, Article ID 857926, 4 pages http://dx.doi.org/10.1155/2013/857926 Case Report Persistent Mosaicism for 12p Duplication/Triplication Chromosome Structural Abnormality
More information